Pharma

Emcure Pharmaceuticals Ltd

EMCURE · NSE · INE168P01015
₹1,956.6+2.16%consolidatedstandalone
Thursday, 10 Sept 202610:46 am
Sentiment67 · Greed
Extreme FearFearNeutralGreedExtreme Greed
Market Cap—
P/E—
P/B—
EPS—
Div Yield—
ROE20.1%
ROCE24.0%
ROE20.1%
1Y Return+30.52%
Avg. Volume0.1M

Price Chart

2,0101,8251,6411,4561,27227.4L54.7LSept 2025Oct 2025Nov 2025Jan 2026Feb 2026Mar 2026Apr 2026Jun 2026Aug 2026

52-Week Range

₹1,260₹1,956.6₹2,048
52W Low52W High

About

Emcure Pharmaceuticals Ltd is a Pharma company listed on NSE.

Pharma

Technicals

Free account

Technicals

Create a free account to view momentum, moving averages, and delivery signals.

Register free

Quant

Premium

Quant metrics

Upgrade to view volatility, drawdown, factor, and risk metrics.

Upgrade

Key Ratios

Market Cap—
Current Price₹1,956.6
52W High / Low₹2,048 / ₹1,260
Stock P/E—
Price to Book—
EPS (TTM)—
Dividend Yield—
ROE20.1%
1Y Return+30.52%
Day Change+2.16%

Profit & Loss

ConsolidatedStandalone
Profit and loss statement
PeriodTTMFY26FY25FY24FY23FY22FY21FY20FY19
Sales₹9,683 Cr₹9,204 Cr₹7,896 Cr
Expenses₹7,703 Cr₹7,458 Cr₹6,427 Cr
Operating Profit₹1,980 Cr₹1,746 Cr₹1,469 Cr
OPM %20.0%19.0%19.0%
Other Income₹-17 Cr₹100 Cr₹62 Cr
Depreciation₹425 Cr₹415 Cr₹384 Cr
Interest₹148 Cr₹144 Cr₹176 Cr
Profit Before Tax₹1,390 Cr₹1,287 Cr₹971 Cr
Tax₹371 Cr₹346 Cr₹264 Cr
Net Profit₹1,019 Cr₹941 Cr₹707 Cr
EPS (₹)53.348.836.0
Dividend Payout %—7%8%
Financial history locked

Register free to see 6 more years.

Register free

Quarterly Results

Quarterly results
QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Sales₹2,580 Cr₹2,470 Cr₹2,363 Cr₹2,270 Cr
Expenses₹2,048 Cr₹1,990 Cr₹1,871 Cr₹1,794 Cr
Operating Profit₹532 Cr₹480 Cr₹493 Cr₹475 Cr
OPM %21.0%19.0%21.0%21.0%
Depreciation₹110 Cr₹106 Cr₹105 Cr₹105 Cr
Interest₹32 Cr₹46 Cr₹38 Cr₹33 Cr
Net Profit₹292 Cr₹244 Cr₹231 Cr₹251 Cr
EPS (₹)15.512.812.212.8
Quarterly history locked

Register free to see 9 more quarters.

Register free

Balance Sheet

Balance sheet
PeriodFY26FY25FY24FY23FY22FY21FY20FY19
Liabilities
Equity Capital₹190 Cr₹189 Cr₹181 Cr
Reserves₹4,760 Cr₹4,257 Cr₹2,771 Cr
Borrowings₹1,521 Cr₹1,023 Cr₹2,335 Cr
Other Liabilities₹3,043 Cr₹2,653 Cr₹2,422 Cr
Total Liabilities₹9,514 Cr₹8,122 Cr₹7,709 Cr
Assets
Fixed Assets₹3,319 Cr₹3,197 Cr₹3,125 Cr
Investments₹20 Cr₹95 Cr₹318 Cr
Receivables———
Inventory———
Cash & Equivalents———
Other Assets₹5,903 Cr₹4,652 Cr₹4,108 Cr
Total Assets₹9,514 Cr₹8,122 Cr₹7,709 Cr
Balance sheet history locked

Register free to see 6 more years.

Register free

Cash Flow

Cash flow statement
PeriodOperatingInvestingFinancingNet Cash Flow
FY26₹944 Cr₹-1,175 Cr₹343 Cr₹112 Cr
FY25₹852 Cr₹-96 Cr₹-814 Cr₹-58 Cr
FY24₹1,097 Cr₹-715 Cr₹-164 Cr₹219 Cr
FY23
FY22
FY21
FY20
FY19
Cash flow history locked

Register free to see 6 more years.

Register free

Peer Comparison

Peer comparison
CompanyM.CapP/EROE1Y Return
Sun Pharmaceutical Industries Ltd——+14.78%+7.18%
Dr Reddys Laboratories Ltd——+8.84%-3.74%
Cipla Ltd——+11.77%-5.50%
Apollo Hospitals Enterprise Ltd——+22.64%+23.01%
Divis Laboratories Ltd₹2,50,065 Cr83.9+16.5%+46.29%

Mutual Fund Holdings

Free account

Mutual fund holdings

Create a free account to see institutional ownership snapshots.

Register free

Bulk & Block Deals

Free account

Bulk & block deals

Create a free account to view recent institutional deal activity.

Register free

Analyst Estimates

Free account

Analyst estimates

Create a free account to view analyst estimate summaries.

Register free

Latest News

2026-09-01Intimation Under Regulations 30 And 36(1)(B) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE Filing2026-08-08Emcure Pharmaceuticals Ltd (BOM:544210) (Q1 2027) Earnings Call Highlights: Revenue Surges 22. ...GuruFocus.com

Documents & Filings

rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.